Why the study?
Proximal LAD lesions associate with adverse prognosis in STEMI, and the study investigated whether beta2-adrenergic receptor autoantibodies associate with proximal LAD lesions.
Are high β2-adrenergic receptor autoantibody levels associated with proximal LAD lesions in patients with STEMI?
Are high β2-adrenergic receptor autoantibody levels associated with proximal LAD lesions in patients with STEMI?
High levels of β2-adrenergic receptor autoantibodies may serve as a biomarker for the presence of high-risk proximal LAD lesions in patients presenting with STEMI.
Answers are grounded in this paper and cite their sources.
May refine STEMI lesion-risk assessment if validated; leaves open causal role and clinical utility of β2-AA.
Background β 2 ‐adrenergic receptor autoantibody (β 2 ‐AA) are widely present in patients with many different types of cardiovascular diseases. Proximal left anterior descending (LAD) artery lesions are associated with adverse prognostic events in patients with ST‐segment elevation myocardial infarction (STEMI). Hypothesis β 2 ‐AA is associated with the presence of proximal LAD lesions in patients with STEMI. Methods A cohort of 153 patients with STEMI who underwent primary percutaneous coronary intervention (PPCI) was enrolled in the study. Baseline characteristics were compared between the proximal LAD group ( n = 62) and the nonproximal LAD group ( n = 91). Admission serum of patients was collected to detect the level of β 2 ‐AA. Data for echocardiogram within 24 hours after PPCI and at the 6‐month follow‐up were recorded. Results The optical density values and positive rates of β 2 ‐AA in the proximal LAD group were higher than those in the nonproximal LAD group ( p < 0.05). β 2 ‐AA positively correlated with high sensitivity C‐reactive protein and peak N‐terminal pro‐B type natriuretic peptide levels in the proximal LAD group, but those were not relevant in the nonproximal LAD group. Multivariate logistic regression analysis revealed that high β 2 ‐AA levels was independently associated with the presence of proximal LAD lesions in patients with STEMI. Furthermore, a receiver operating characteristic curve was used to show the efficiency of β 2 ‐AA levels to detect proximal LAD lesions, and the AUC of the β2‐AA OD value was 0.658 (95% confidence interval 0.568−0.749; p = 0.001). Conclusions The STEMI patients with high β 2 ‐AA levels had a greater possibility having proximal LAD lesions.
No takes yet. Share an insight, caveat, or question.
Dang et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: